The use of antidepressants by children and adolescents: An integrative review
DOI:
https://doi.org/10.33448/rsd-v13i5.45889Keywords:
Depressive disorder; Antidepressive agents; Child; Adolescent.Abstract
Depression, a chronic and recurrent psychiatric condition, is characterized by emotional fluctuations, including irritability, lack of motivation, changes in sleep and appetite, persistent feelings of sadness, distress, and guilt, as well as low self-esteem, associated with difficulty concentrating, suicidal thoughts, and indecision. The aim of this study was to describe the outcomes of pharmacotherapy used in the treatment of depression in children and adolescents. An integrative review was conducted in the MEDLINE and LILACS databases using the descriptors: Depressive Disorder, Antidepressive Agents, Child and Adolescent. Full-text articles published in the last five years, in English, Portuguese, or Spanish, addressing children and adolescents, were included. Repeated studies, reviews, dissertations or theses, or those that did not address pharmacological treatment outcomes were excluded. The final sample comprised eight articles. The effectiveness of pharmacotherapeutic interventions, such as the use of ketamine and fluvoxamine, in reducing depressive symptoms in children and adolescents, while also suggesting an association between levels of inflammatory cytokines and the severity of depressive symptoms, as well as highlighting the influence of personality traits on antidepressant treatment response. It is concluded that pharmacological interventions were associated with significant improvements in depressive symptoms, ranging from the use of intravenous ketamine, fluvoxamine, conventional antidepressants, and sertraline.
References
Bakker, M. H., Hugtenburg, J. G., Smits, M. G., van der Horst, H. E., & Slottje, P. (2023). Off‐label low dose amitriptyline for insomnia disorder: Patient‐reported outcomes. Pharmacoepidemiology and drug safety, 32(4), 435-445.
Botero, B. F., Figueiredo, E. F. G., da Costa, J. E. B., de Oliveira Magalhães, M. N., de Almeida, P. H. F., Martim, S. R., & da Silva, Y. T. P. (2022). Eficácia e riscos do uso de psicofármacos em crianças e adolescentes com transtornos de depressão: uma revisão bibliográfica. Research, Society and Development, 11(14).
Dwyer, J. B., Landeros-Weisenberger, A., Johnson, J. A., Londono Tobon, A., Flores, J. M., Nasir, M., ... & Bloch, M. H. (2021). Efficacy of intravenous ketamine in adolescent treatment-resistant depression: a randomized midazolam-controlled trial. American Journal of Psychiatry, 178(4), 352-362.
França, E. O., Fernandes, M. L. A., Santana, N. M. C., & Dunningham, W. A. (2022). Fatores de risco para depressão na adolescência: uma revisão sistemática. Revista Brasileira de Neurologia e Psiquiatria, 26(1).
Gill, H., Gill, B., El‐Halabi, S., Chen‐Li, D., Lipsitz, O., Rosenblat, J. D., ... & Mcintyre, R. S. (2020). Antidepressant medications and weight change: a narrative review. Obesity, 28(11), 2064-2072.
Goryunov, A. V., Golubeva, N. I., & Shushpanova, O. V. (2023). Experience of clinical use of fluvoxamine for the treatment of comorbid depression in childhood and adolescence. Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova, 123(11. Vyp. 2), 14-21.
Kloosterboer, S. M., Vierhout, D., Stojanova, J., Egberts, K. M., Gerlach, M., Dieleman, G. C., ... & Koch, B. C. (2020). Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic review. Expert Opinion on Drug Safety, 19(7), 873-890.
Lee, H., Song, M., Lee, J., Kim, J. B., & Lee, M. S. (2020). Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder. Journal of affective disorders, 266, 57-62.
Lineham, A., Avila-Quintero, V. J., Bloch, M. H., & Dwyer, J. (2024). Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression. Journal of Child and Adolescent Psychopharmacology.
Lineham, A., Avila-Quintero, V. J., Bloch, M. H., & Dwyer, J. (2023). The relationship between acute dissociative effects induced by ketamine and treatment response in adolescent patients with treatment-resistant depression. Journal of Child and Adolescent Psychopharmacology, 33(1), 20-26.
Liu, C. C., Lan, C. C., & Chen, Y. S. (2024). The use of sertraline to treat an adolescent of dystonia comorbid with major depressive disorder with psychotic features. Neuropsychopharmacology Reports, 44(1), 275-279.
Mendes, K. D. S., Silveira, R. C. D. C. P., & Galvão, C. M. (2019). Uso de gerenciador de referências bibliográficas na seleção dos estudos primários em revisão integrativa. Texto & Contexto-Enfermagem, 28, e20170204.
Oliva, V., Lippi, M., Paci, R., Del Fabro, L., Delvecchio, G., Brambilla, P., ... & Serretti, A. (2021). Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: a systematic review and meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 109, 110266.
Ran, L. Y., Liu, X. Y., Wang, W., Tao, W. Q., Xiang, J. J., Zeng, Q., ... & Kuang, L. (2024). Personality traits predict treatment outcome of an antidepressant in untreated adolescents with depression: An 8-week, open-label, flexible-dose study. Journal of Affective Disorders, 350, 102-109.
Saha, K., Torous, J., Kiciman, E., & De Choudhury, M. (2021). Understanding side effects of antidepressants: large-scale longitudinal study on social media data. JMIR mental health, 8(3), e26589.
Santos, C. M. D. C., Pimenta, C. A. D. M., & Nobre, M. R. C. (2007). A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Revista latino-americana de enfermagem, 15, 508-511.
da Silva, O. R. T., & da Silveira, M. M. (2019). O uso de psicofármacos por crianças e adolescentes em um Centro de Atenção Psicossocial Infantil. Infarma-Ciências Farmacêuticas, 31(3), 210-218.
Stutzman, D. L. (2021). Long-term use of antidepressants, mood stabilizers, and antipsychotics in pediatric patients with a focus on appropriate deprescribing. Mental Health Clinician, 11(6), 320-333.
Teng, T., Zhang, Z., Yin, B., Guo, T., Wang, X., Hu, J., ... & Zhou, X. (2022). Effect of antidepressants on functioning and quality of life outcomes in children and adolescents with major depressive disorder: a systematic review and meta-analysis. Translational Psychiatry, 12(1), 183.
Zhang, C., Zafari, Z., Slejko, J. F., Castillo, W. C., Reeves, G. M., & Dosreis, S. (2023). Impact of undertreatment of depression on suicide risk among children and adolescents with major depressive disorder: A microsimulation study. American journal of epidemiology, 192(6), 929-938.
Zuanazzi, C. A., & Grazziotin, N. A. (2020). Análise da dispensação de antidepressivos e ansiolíticos em uma farmácia comercial do Noroeste do Rio Grande do Sul. Revista Perspectiva, 44(165), 153-160.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Greison Antonio dos Santos; Daniele Bastos dos Santos; Cristiane Gomes Lima
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
